Search Results - "Tarpin, C"
-
1
RETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer
Published in Annals of oncology (01-09-2018)Get full text
Journal Article -
2
Effects of termite sheetings on soil properties under two contrasting soil management practices
Published in Pedobiologia (01-09-2019)“…•Termite sheetings substantially improved soil properties.•Termite activity sequester organic matter in sheetings.•Termite activity improves soil properties in…”
Get full text
Journal Article Web Resource -
3
Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes
Published in ESMO open (01-02-2024)“…Sexual concerns are a major unaddressed need among survivors of breast cancer (BC) with significant negative effects on quality of life. We longitudinally…”
Get full text
Journal Article -
4
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation
Published in Bone marrow transplantation (Basingstoke) (01-08-2016)“…Breast cancer carrying BRCA mutation may be highly sensitive to DNA-damaging agents. We hypothesized a better outcome for BRCA-mutated (BRCA mut ) metastatic…”
Get full text
Journal Article -
5
Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma
Published in British journal of cancer (01-10-2013)“…Background: Sunitinib is a tyrosine kinase inhibitor approved for the treatment of renal cell carcinoma (RCC). Few data evaluated severe buccodental adverse…”
Get full text
Journal Article -
6
Factors associated with enrolment in clinical trials among women with early-stage breast cancer
Published in ESMO open (01-06-2022)“…Clinical trials allow development of innovative treatments and ameliorate the quality of clinical care in oncology. Data show that only a minority of patients…”
Get full text
Journal Article -
7
-
8
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study
Published in BMC cancer (14-10-2015)“…Anthracycline-based adjuvant chemotherapy improves survival in patients with high-risk node-negative breast cancer (BC). In this setting, prognostic factors…”
Get full text
Journal Article -
9
Participants' uptake of clinical trial results: a randomised experiment
Published in British journal of cancer (30-03-2010)“…Background: Participants are showing great interest these days in obtaining the results of clinical trials. The aim of this study was to assess patients’…”
Get full text
Journal Article -
10
Quality of life in a heterogeneous sample of caregivers of cancer patients: an in-depth interview study
Published in European journal of cancer care (01-07-2011)“…MANCINI J., BAUMSTARCK‐BARRAU K., SIMEONI M.‐C., GROB J.‐J., MICHEL G., TARPIN C., LOUNDOU A.‐D., LAMBERT A., CLÉMENT A. & AUQUIER P. (2010) European Journal…”
Get full text
Journal Article -
11
High-dose Alkylating Agents with Autologous Hematopoietic Stem Cell Support and Trastuzumab in ERBB2 Overexpressing Metastatic Breast Cancer: A Feasibility Study
Published in Anticancer research (01-01-2005)“…Background: ERBB2 overexpression predicts a worse outcome for patients receiving high-dose chemotherapy (HDC). Trastuzumab improves response rate and survival…”
Get full text
Journal Article -
12
Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors
Published in Anticancer research (01-07-2003)“…To determine the maximum tolerated dose of the combination of Carboplatin and Caelyx, a pegylated liposomal doxorubicin, with promising activities in various…”
Get more information
Journal Article -
13
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment
Published in Bone marrow transplantation (Basingstoke) (01-05-2004)“…The prognosis of inflammatory breast cancer (IBC) is poor. We evaluated clinical and biopathological characteristics that could affect survival in 74 women…”
Get full text
Journal Article -
14
2PRETROSPHER. ERBB2 amplification detection in the plasma at diagnosis for early high-risk HER2-positive breast cancer
Published in Annals of oncology (01-09-2018)Get full text
Journal Article -
15
-
16
166P Metabolomic prediction of breast cancer treatment toxicities
Published in Annals of oncology (01-10-2023)Get full text
Journal Article -
17
1558MO Dissecting sexual health after breast cancer (BC) by longitudinal assessment of patient reported outcomes
Published in Annals of oncology (01-09-2022)Get full text
Journal Article -
18
134P Enrolment in clinical trials (CT) among patients (pts) with early breast cancer (BC)
Published in Annals of oncology (01-09-2021)Get full text
Journal Article -
19
-
20